Double Blind Placebo COntrolled Dose Ranging studY of the eFficacy and safEty of SSR149744c 300 or 600 mg for the Conversion of Atrial Fibrillation / fluttEr
Clinical trial NCT00232310 · COMPLETED
Trial details
- NCT number
- NCT00232310
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2006-04-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.